Cancer vaccines (Part 1 of 2)

P. A. Hallin, V. R. Adams

Research output: Contribution to journalShort surveypeer-review


Several cancer vaccines are in various phases of clinical research. As vaccine therapy evolves, this method of treatment and/or preventing cancer will become more common. Part 2 of this column will describe some of the current vaccine studies and where vaccine therapy may be headed in the future.

Original languageEnglish
Pages (from-to)598-599
Number of pages2
JournalJournal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Issue number5
StatePublished - 1997

Bibliographical note

Funding Information:
is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Pharmacy, and supported by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Cancer vaccines (Part 1 of 2)'. Together they form a unique fingerprint.

Cite this